Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.



Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV (6th edition)

Cover Page
  • Authors: Dedov I.I.1, Shestakova M.V.1, Aleksandrov A.A.1, Galstyan G.R.1, Grigoryan O.R.1, Esayan R.M.2, Kalashnikov V.Y.1, Kuraeva T.L.1, Lipatov D.V.1, Mayorov A.Y.1, Peterkova V.A.1, Smirnova O.M.1, Starostina E.G.3, Surkova E.V.1, Sukhareva O.Y.1, Tokmakova A.Y.1, Shamkhalova M.S.1, Yarek-Martynova I.R.1
  • Affiliations:
    1. Endocrinology Research Centre, Moscow
    2. Sechenov First Moscow State Medical University
    3. Vladimirsky Moscow Regional Research and Clinical Institute
  • Issue: Vol 16, No 1S (2013): STANDARDS OF SPECIALIZED DIABETES CARE
  • Pages: 1-120
  • Section: Regulatory documents
  • URL: https://dia-endojournals.ru/dia/article/view/6274
  • DOI: https://doi.org/10.14341/DM20131S1-121
  • Cite item

Abstract


Dear Colleagues!.
We are glad to present the 6th Edition of Standards of Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation. The Standards are updated on the regular basis to incorporate new data and relevant recommendations from national and international clinical societies, including World Health Organization Guidelines (WHO, 2011), International Diabetes Federation (IDF, 2011), American Diabetes Association (ADA, 2013), American Association of Clinical Endocrinologists (AACE, 2009), International Society for Pediatric and Adolescent Diabetes (ISPAD, 2009) and Russian Association of Endocrinologists (RAE, 2011, 2012). Current edition of the ?Standards? also integrates results of completed randomized clinical trials (ADVANCE, ACCORD, VADT, UKPDS, etc.), as well as findings from the national studies of diabetes mellitus (DM), conducted in close partnership with a number of Russian hospitals.
Latest data indicates that prevalence of DM increased during the last decade more than two-fold, reaching some 371 million patients by 2013. According to the current estimation by the International Diabetes Federation, every tenth inhabitant of the planet will be suffering from DM by 2030. These observations resulted in the UN Resolution 61/225 passed on 20.12.2006 that encouraged all Member States ?to develop national policies for the prevention, treatment and care of diabetes?.
Like many other countries, Russian Federation experiences a sharp rise in the prevalence of DM. According to Russian State Diabetes Register, there are at least 3.799 million patients with DM in this country. However, the epidemiological survey conducted by the Federal Endocrinology Research Centre during 2002-2010 suggests that actual prevalence is 3 to 4 times greater than the officially recognized and, by this estimate, amounts to 9-10 million persons, comprising 7% of the national population. .
Severe consequences of the global pandemics of DM include its vascular complications: nephropathy, retinopathy, coronary, cerebral and peripheral vascular disease. These conditions are responsible for the majority of cases of diabetes-related disability and death. .
Current edition of the ?Standards? emphasizes the patient-oriented approach in making decisions on therapeutic goals, such as levels of glycaemia and blood pressure. It also features updated guidelines on the management of vascular complications and new RAE position statement on gestational diabetes, produced in collaboration with Russian Association of Obstetrics and Gynecology. .
This text represents a consensus by the absolute majority of national experts, achieved through a number of fruitful discussions held at national meetings and forums. These guidelines are intended for endocrinologists and diabetologists, primary care physicians, cardiologists and other medical professionals involved in prevention and treatment of diabetes mellitus.

Ivan Ivanovich Dedov

Endocrinology Research Centre, Moscow

Author for correspondence.
Email: dedov@endocrincentr.ru

Russian Federation

President of the Russian Academy of Medical Sciences, Fellow of the Russian Academy of Sciences, Chief Endocrinologist of the Ministry of Healthcare of the Russian Federation

Marina Vladimirovna Shestakova

Endocrinology Research Centre, Moscow

Email: nephro@endocrincentr.ru

Russian Federation

MD, PhD, Professor, Corresponding Fellow of the Russian Academy of Medical Sciences, Director of Diabetes Institute

Andrey Alexeevich Aleksandrov

Endocrinology Research Centre, Moscow

Email: post@endocrincentr.ru

Russian Federation Professor, Head of the Department of Cardiology

Gagik Radikovich Galstyan

Endocrinology Research Centre, Moscow

Email: foot@endocrincentr.ru

Russian Federation Professor, Head of the Department of Diabetic Foot

Olga Rafael'evna Grigoryan

Endocrinology Research Centre, Moscow

Email: post@endocrincentr.ru

Russian Federation PhD, Chief Researcher of the Department of Reproduction Technologies

Rosa Mikhailovna Esayan

Sechenov First Moscow State Medical University

Email: rosaes@mail.ru

Russian Federation Teaching fellow of the Chair of Endocrinology and Diabetology, Paediatric Faculty

Victor Yur'evich Kalashnikov

Endocrinology Research Centre, Moscow

Email: post@endocrincentr.ru

Russian Federation Professor, Head of the Department of Diabetology

Tamara Leonidovna Kuraeva

Endocrinology Research Centre, Moscow

Email: post@endocrincentr.ru

Russian Federation Professor, Head of the Department of Diabetology

Dmitriy Valentinovich Lipatov

Endocrinology Research Centre, Moscow

Email: post@endocrincentr.ru

Russian Federation PhD, Head of the Department of Diabetic Retinopathy and Ophthalmic Surgery

Alexander Yur'evich Mayorov

Endocrinology Research Centre, Moscow

Email: education@endocrincentr.ru

Russian Federation PhD, Head of the Department of Diabetes Education

Valentina Alexandrovna Peterkova

Endocrinology Research Centre, Moscow

Email: post@endocrincentr.ru

Russian Federation

Corresponding Member of the Russian Academy of Medical Sciences, Director of Paediatric Endocrinology Institute

Olga Mikhailovna Smirnova

Endocrinology Research Centre, Moscow

Email: dr_smr@mail.ru

Russian Federation Professor, Chief Researcher of the Department of Diabetes Education

Elena Georgievna Starostina

Vladimirsky Moscow Regional Research and Clinical Institute

Email: post@endocrincentr.ru

Russian Federation Professor, Department of Endocrinology

Elena Viktorovna Surkova

Endocrinology Research Centre, Moscow

Email: post@endocrincentr.ru

Russian Federation PhD, Senior Researcher of the Department of Diabetes Education

Olga Yur'evna Sukhareva

Endocrinology Research Centre, Moscow

Email: post@endocrincentr.ru

Russian Federation

Candidate of Medical Sciences, Senior Researcher of the Department of Diabetic Nephropathy

Alla Yur'evna Tokmakova

Endocrinology Research Centre, Moscow

Email: foot@endocrincentr.ru

Russian Federation PhD, Chief Researcher of the Department of Diabetic Foot

Minara Shamkhalovna Shamkhalova

Endocrinology Research Centre, Moscow

Email: shamkhalova@mail.ru

Russian Federation PhD, Head of the Department of Diabetic Nephropathy

Ivona Renata Yarek-Martynova

Endocrinology Research Centre, Moscow

Email: post@endocrincentr.ru

Russian Federation

Candidate of Medical Sciences, Senior Researcher of the Department of Diabetic Nephropathy

  1. Dedov I, Krasnopol'skiy V, Sukhikh G. Russian National Consensus Statement on gestational diabetes: diagnostics, treatment and postnatal care. Diabetes mellitus. 2012;(4):4-10. doi: 10.14341/2072-0351-5531
  2. Dedov I, Peterkova V, Kuraeva T. Rossiyskiy konsensus po terapii sakharnogo diabeta u detey i podrostkov. Diabetes mellitus. 2010;(5):1-8. doi: 10.14341/2072-0351-6048
  3. Dedov I, Shestakova M, Ametov A, Antsiferov M, Galstyan G, Mayorov A, Mkrtumyan A, Petunina N, Sukhareva O. Russian Association of Endocrinologists expert consensus document on initiation and intensification of antyhyperglycaemic therapy in type 2 diabetes mellitus. Diabetes mellitus 2011;(4):6-17. doi: 10.14341/2072-0351-5810
  4. Dedov I, Shestakova M, et al. Optimizatsiya i intensifikatsiya insulinoterapii pri sakharnom diabete 2 tipa (klinicheskie rekomendatsii). Diabetes mellitus 2010;(5):9-16. doi: 10.14341/2072-0351-6049
  5. Dedov II, Shestakova MV. Diabetes mellitus and arterial hypertension. Moscow: Meditsinskoe informatsionnoe agentstvo; 2006. 344p.
  6. Diagnostika i lechenie bol'nykh ostrym infarktom miokarda s pod'emom segmenta ST elektrokardiogrammy. Russian guidelines. Moscow; 2007. www.cadriosite.ru
  7. Klinicheskie rekomendatsii. Kardiologiya. Ed by Belenkov YuN, Oganov RG. Moscow: GEOTAR-Media; 2007. 640p.
  8. Potemkin VV, Starostina EG. Rukovodstvo po neotlozhnoy endokrinologii. Moscow: Meditsinskoe informatsionnoe agentstvo; 2008. 393p.
  9. Rekomendatsii po lecheniyu ostrogo koronarnogo sindroma bez stoykogo pod'ema segmenta ST na EKG. Russian guidelines. Moscow; 2008. www.cadriosite.ru
  10. Diabetes mellitus: diagnosis, treatment, prophilaxis. Ed by Dedov II, Shestakova MV. Moscow: Meditsinskoe informatsionnoe agentstvo; 2011.
  11. Diabetes mellitus: acute and chronic complications. Ed by Dedov II, Shestakova MV. Moscow: Meditsinskoe informatsionnoe agentstvo; 2011.
  12. ISPAD Clinical Practice Consensus Guidelines 2009. Pediatric Diabetes. 2009;10(Suppl 12):1-210.
  13. Shestakova MV, Dedov II. Diabetes mellitus and chronic kidney disease. Moscow: Meditsinskoe informatsionnoe agentstvo; 2009. 500p.
  14. American Diabetes Association. Standards of medical care in diabetes – 2013. Diabetes Care 2013; 36 Suppl 1:11-66. doi: 10.2337/dc11-S011.
  15. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. European Heart Journal 2007 May;28(13):1598-1660. doi: 10.1093/eurheartj/ehm161.
  16. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of WHO/IDF Consultation. 2006.
  17. Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO consultation. Part 1: Di agnosis and Classification of Diabetes Mellitus (WHO/NCD/NCS/99.2). Geneva: World Health Organization; 1999.
  18. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009 Jan;360(2):129-139. doi: 10.1056/NEJMoa0808431.
  19. Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, et al. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008 Jun;358(24):2545-2559. doi: 10.1056/NEJMoa0802743.
  20. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). European Heart Journal Supplements 2007; 9 (Supplement C). doi: 10.1093/eurheartj/ehl261.
  21. International Diabetes Federation. Diabetes Atlas 6th Edition. 2013.
  22. International Diabetes Federation. Global Guideline for Type 2 diabetes. 2012.
  23. International Diabetes Federation. Guideline for management of postmeal glucose. 2011.
  24. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD).Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012; 35(6):1364-79. doi: 10.2337/dc12-0413
  25. Kushner FG, Hand M, Smith Jr SC, King 3rd SB, Anderson JL, Antman EM, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009 Dec;54(23):2205-2241. doi: 10.1016/j.jacc.2009.10.015.
  26. Mancia G, Backer, G. De , Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC. European Heart Journal 2006 Dec;28(12):1462-1536. doi: 10.1093/eurheartj/ehm236.
  27. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009 Jan;32(1):193-203. doi: 10.2337/dc08-9025.
  28. Patel A, MacMahon S. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008 Jun;358(24):2560-2572. doi: 10.1056/NEJMoa0802987.
  29. Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control. Endocrine Practice 2009;15(6):540-559. doi: 10.4158/EP.15.6.540.
  30. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2008 Dec;32(1):187-192. doi: 10.2337/dc08-9026.
  31. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation (WHO/NMH/CHP/CPM/11.1). World Health Organization; 2011.
  32. Wijns W, Kolh P, Danchin N, Mario, C. Di , Falk V, Folliguet T, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal;31(20):2501-2555. doi: 10.1093/eurheartj/ehq277.
  33. Wright, R. Scott, , Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline). Journal of the American College of Cardiology 2011;57(19):1920-1959. doi: 10.1016/j.jacc.2011.02.009.

Views

Abstract - 7758

HTML (Russian) - 3529

PDF (Russian) - 1763

Cited-By


PlumX


Copyright (c) 2013 Dedov I.I., Shestakova M.V., Aleksandrov A.A., Galstyan G.R., Grigoryan O.R., Esayan R.M., Kalashnikov V.Y., Kuraeva T.L., Lipatov D.V., Mayorov A.Y., Peterkova V.A., Smirnova O.M., Starostina E.G., Surkova E.V., Sukhareva O.Y., Tokmakova A.Y., Shamkhalova M.S., Yarek-Martynova I.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies